Peptides derived from self-proteins as partial agonists and antagonists of human CD8+ T-cell clones reactive to melanoma/melanocyte epitope MART127-35

Cancer Research

Volumn 58, Issue 11, 1998, Pages 2433-2439

  Loftus, Douglas J ^a   Squarcina, Paola ^b   Nielsen, Mai Britt ^c   Geisler, Carsten ^c   Castelli, Chiara ^b   Ødum, Niels ^c   Appella, Ettore ^a   Parmiani, Giorgio ^b   Rivoltini, Licia ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CYTOKINE; EPITOPE; GAMMA INTERFERON; HLA A ANTIGEN; INTERLEUKIN 2; PEPTIDE; PROTEIN; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOLYSIS; CYTOTOXICITY; HUMAN; HUMAN CELL; MELANOMA; PHOSPHORYLATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIGENS, NEOPLASM; AUTOANTIGENS; CLONE CELLS; CYTOTOXICITY, IMMUNOLOGIC; DATABASES, FACTUAL; EPITOPE MAPPING; EPITOPES; HLA-A2 ANTIGEN; HUMANS; INTERLEUKIN-2; MELANOCYTES; MELANOMA; NEOPLASM PROTEINS; PEPTIDE LIBRARY; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 0032100538     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Nakano, N., Rooke, R., Benoist, C., and Mathis, D. Positive selection of T cells induced by viral delivery of neopeptides to the thymus. Science (Washington DC), 275: 678-683, 1997.
2. Ignatowicz, L., Rees, W., Pacholczyk, R., Ignatowicz, H., Kushnir, E., Kappler, J., and Marrack, P. T cells can be activated by peptides that are unrelated in sequence to their selecting peptide. Immunity, 7: 179-186, 1197.
3. Hogquist, K. A., Jameson, S. C., Heath, W. R., Howard, J. L., Bevan, M. J., and Carbone, F. R. T cell receptor antagonist peptides induce positive selection. Cell, 76: 17-27, 1994.
4. Grubin, C. E., Kovats, S., deRoos, P., and Rudensky, A. Y. Deficient positive selection of CD4 T cells in mice displaying altered repertoires of MHC class II-bound self peptides. Immunity, 7: 197-208, 1997.
5. Surh, C. D., Lee, D-S., Fung-Leung, W., Karlsson, L., and Sprent, J. Thymic selection by a single MHC/peptide ligand produces a semidiverse repertoire of CD4+ T cells. Immunity, 7: 209-219, 1997.
6. Hu, G., Bazemore Walker, C. R., Girao, C., Opferman, J. T., Sun, J., Shabanowitz, J., Hunt, D. F., and Ashton-Rickardt, P. G. Specific recognition of thymic self-peptides induces the positive selection of cytotoxic T lymphocytes. Immunity, 7: 221-231, 1997.
7. Bevan, M. J. In thymic selection, peptide diversity gives and takes away. Immunity, 7: 175-178, 1997.
8. Vidal, K., and Allen, P. M. The effect of endogenous altered peptide ligands on peripheral T-cell responses. Semin. Immunol., 8: 117-122, 1996.
9. Grossman, Z., and Singer, A. Tuning of activation thresholds explains flexibility in the selection and development of T cells in the thymus. Proc. Natl. Acad. Sci. USA., 93: 14747-14752, 1996.
10. Williams, O., Tanaka, Y., Tarazona, R., and Kioussis, D. The agonist-antagonist balance in positive selection. Immunol. Today, 18: 121-126, 1997.
11. Matsushita, S., Kohsaka, H., and Nishimura, Y. Evidence for self and nonself peptide partial agonists that prolong clonal survival of mature T cells vitro. J. Immunol., 158: 5685-5691, 1997.
12. Tanchot, C., Lemmonier, F. A., Perarnau, B., Freitas, A. A., and Rocha, B. Differential requirements for survival and proliferation of CD8 naive or memory T cells. Science (Washington DC), 276: 2057-2062, 1997.
13. Beverly, P. C. Is T-cell memory maintained by cross-reactive stimulation? Immunnol. Today, 11: 203-205, 1990.
14. Kersh, G. J., and Allen, P. M. Essential flexibility in the T-cell recognition of antigen. Nature (Lond.), 380: 495-498, 1996.
15. Boon, T., Coulie, P. G., and Van den Eynde, B. Tumor antigens recognized by T cells. Immunol. Today, 18: 267-268, 1997.
16. Coulie, P. G., Brichard, V., Van Pel, A., Wolfel, T., Schneider, J., Traversari, C., Mattei, S., De Plaen, E., Lurquin, C., Szikora, J. P., Renauld, J. C., and Boon, T. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med., 180: 35-42, 1994.
17. Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Rivoltini, L., Topalian, S. L., Miki, T., and Rosenberg, S. A. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. Natl. Acad. Sci. USA, 91: 3515-3519, 1994.
18. Kawakami, Y., Eliyahu, S., Sakaguchi, K., Robbins, P. F., Rivoltini, L., Yannelli, J. R., Appella, E., and Rosenberg, S. A. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J. Exp. Med., 180: 347-352, 1994.
19. Spagnoli, G. C., Schaefer, C., Willimann, T. E., Kocher, T., Amoroso, A., Juretic, A., Zuber, M., Luscher, U., Harder, F., and Heberer, M. Peptide-specific CTL in tumor infiltrating lymphocytes from metastatic melanomas expressing MART-1/Melan-A, gp100 and tyrosinase genes: a study in an unselected group of HLA-A2.1-positive patients. Int. J. Cancer, 64: 309-315, 1995.
20. Rivoltini, L., Kawakami, Y., Sakaguchi, K., Southwood, S., Sette, A. Robbins, P. F., Marincola, F. M., Salgaller, M. L., Yannelli, J. R., Appella, E., and Rosenberg, S. A. Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1. J. Immunol., 154: 2257-2265, 1995.
21. Stevens, E. J., Jacknin, L., Robbins, P. F., Kawakami, Y., El-Gamil, M., Rosenberg, S. A., and Yannelli, J. R. Generation of tumor-specific CTLs from melanoma patients by using peripheral blood stimulated with allogeneic melanoma tumor cell lines. Fine specificity and MART-1 melanoma antigen recognition. J. Immunol., 154: 762-771, 1995.
22. Cormier., J. N., Salgaller, M. L., Prevette, T. Barracchini, K. C., Rivoltini, L., Restifo, N. P., Rosenberg, S. A., and Marincola, F. M. Enhancement of cellular immunity in melanoma patients immunized with a peptide from MART-1/Melan A. Cancer J. Sci. Am., 3: 37-44, 1997.
23. 27-35. J. Exp. Med., 184: 647-657, 1996.
24. Evavold, B. D., Sloan-Lancaster, J., and Allen, P. M. Tickling the TCR. Selective T-cell functions stimulated by altered peptide ligands. Immunol. Today, 14: 602-609, 1993.
25. Madrenas, J., and Germain, R. N. Variant TCR ligands: new insights into the molecular basis of antigen-dependent signal transduction and T-cell activation. Semin. Immunol., 8: 83-101, 1996.
26. Walter, E. A., Greenberg, P. D., Gilbert, M. J., Finch, R. J., Thomas, E. D., and Riddell, S. R. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med. 333: 1038-1044, 1995.
27. Cole, D. J., Weil, D. P., Shamamian, P., Rivoltini, L., Kawakami, Y., Topalian, S., Jennings, C., Eliyahu, S., Rosenberg, S. A., and Nishimura, M. I. Identification of MART-1-specific T-cell receptors: T cells utilizing distinct T-cell receptor variable and joining regions recognize the same tumor epitope. Cancer Res., 54: 5265-5268, 1994.
28. Ljunggren, H. G., Stam, N. J., Ohlen, C., Neefjes, J. J., Hoglund, P., Heemels, M. T., Bastin, J., Schumacher, T. N., Townsend, A., Karre, K., and Ploegh, H. Empty MHC class I molecules come out in the cold. Nature (Lond.), 346: 476-480, 1990.
29. Milford, E. L., Kennedy, L. J., Yang, S. Y., Dupont, B., Lalouel, J-M., and Yunis, E. J. Serological characterization of the reference panel of B-lymphoblastoid cell lines for factors of the HLA system. In: B. Dupont (ed.), Immunobiology of HLA: Histocompatibility Testing, Vol. 1, p. 19. New York: Springer-Verlag New York, Inc., 1987.
30. Nielsen, M., Kaltoft, K., Nordahl, M., Ropke, C., Geisler, C., Mustelin, T., Dobson, P., Svejgaard, A., and Ødum, N. Constitutive activation of a slowly migrating isoform of Stat3 in mycosis fungoides: Tyrphostin AG490 inhibits Stat3 activation and growth of mycosis fungoides tumor cell lines. Proc. Natl. Acad. Sci. USA, 94: 6764-6769, 1997.
31. Rivoltini, L., Loftus, D. J., Barracchini, K., Arienti, F., Mazzocchi, A., Biddison, W. E., Salgaller, M., Appella, E., Parmiani, G., and Marincola, F. Binding and presentation of peptides derived from melanoma antigens MART-1 and gp100 by HLA-A2 subtypes: implications for peptide-based immunotherapy. J. Immunol., 156: 3882-3891, 1996.
32. Pearson, W. R., and Lipman, D. J. Improved tools for biological sequence comparison. Proc. Natl. Acad. Sci. USA, 85: 2444-2448, 1988.
33. Wucherpfennig, K. W., and Strominger, J. L. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell, 80: 695-705, 1995.
34. Croft, M., Carter, L., Swain, S. L., and Dutton, R. W. Generation of polarized antigen-specific CD8 effector populations: reciprocal actions of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles. J. Exp. Mod., 180: 1715-1728, 1994.
35. Evavold, B. D., Sloan-Lancaster, J., Hsu, B. L., and Allen, P. M. Separation of T helper 1 clone cytolysis from proliferation and lymphokine production using analog peptides. J. Immunol., 150: 3131-3140, 1993.
36. Valitutti, S., Muller, S., Dossing, M., and Lanzavecchia, A. Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy. J. Exp. Med., 183: 1917-1921, 1996.
37. Valitutti, S., Dessing, M., Aktories, K., Gallati, H., and Lanzavecchia, A. Sustained signalling leading to T cell activation results from prolonged T cell receptor occupancy. Role of actin cytoskeleton. J. Exp. Med., 181: 577-584, 1995.
38. Jameson, S. C., Carbone, F. R., and Bevan, M. J. Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells. J. Exp. Med., 177: 1541-1550, 1993.
39. Sloan-Lancaster, J., Shaw, A. S., Rothbard, J. B., and Allen, P. M. Partial T cell signaling: altered phospho-ζ and lack of ZAP-70 recruitment in APL-induced T cell anergy. Cell, 79: 913-922, 1994.
40. Reis e Sousa, C., Levine, E. H., and Germain, R. N. Partial signalling by CD8+ T cells in response to antagonist ligands. J. Exp. Med., 184: 149-157, 1996.
41. Vidal, K., Hsu, B. L., Williams, C. B., and Allen, P. M. Endogenous altered peptide ligands can affect peripheral T cell responses. J. Exp. Med., 183: 1311-1321, 1996.
42. Madrenas, J., Chau, L. A., Smith, J., Bluestone, J. A., and Germain, R. N. The efficiency of CD4 recruitment to ligand-engaged TCR controls the agonist/partial agonist properties of peptide-MHC molecule ligands. J. Exp. Med., 185: 219-229, 1997.
43. Chambers, C. A., and Allison, J. P. Costimulation in T cell responses, Curr. Opin. Immunol., 9: 396-404, 1997.
44. Mueller, D. L., Seiffert, S., Fang, W., and Behrens, T. W. Differential regulation of bcl-2 and and bcl-x by CD3, CD28, and the IL-2 receptor in cloned CD4+ helper T cells: a model for the long term survival of memory cells. J. Immunol., 156: 1764-1771, 1996.
45. Whiteside, T. L., and Parmiani, G. Tumor-infiltrating lymphocytes: their phenotype, functions and clinical use. Cancer Immunol. Immunother., 39: 15-21, 1994.
46. Gervois, N., Guilloux, Y., Diez, E., and Jotereau, F. Suboptimal activation of melanoma infiltrating lymphocytes (TIL) due to low avidity of TCR/MHC-tumor peptide interactions. J. Exp. Med., 183: 2403-2407, 1996.
47. Sugita, S., Sagawa, K., Mochizuki, M., Shichijo, S., and Itoh, K. Melanocyte lysis by cytotoxic T lymphocytes recognizing the MART-1 melanoma antigen in HLA-A2 patients with Vogt-Koyanagi-Harada disease. Int. Immunol., 5: 799-803, 1996.
48. Sad, S., and Mosmann, T. R. Interleukin (IL) 4, in the absence of antigen stimulation, induces an anergy like state in differentiated CD8+ TC1 cells: loss of IL-2 synthesis synthesis and autonomous proliferation but retention of cytotoxicity and synthesis of other cytokines. J. Exp. Med., 182: 1505-1515, 1995.
49. Sad, S., and Mosmann, T. R. Cytokine-deficient CD8+ Tc1 cells induced by I1-4. Retained inflammation and perform and Fas cytotoxicity but compromised long term killing of tumor cells. J. Immunol., 159: 606-613, 1997.
50. Nicholson, L. B., Murtaza, A., Hafler, B. P., Sette, A., and Kuchroo, V. A T cell receptor antagonist peptide induces T cells that mediate bystander suppression and prevent auioimmune encephalomyelitis induced with multiple myelin antigens. Proc. Natl. Acad. Sci. USA, 94: 9279-9284, 1997.
51. Madrenas, J., Schwartz, R. H., and Germain, R. N. Interleukin 2 production, not the pattern of early T-cell antigen receptor-dependent tyrosine phosphorylation, controls anergy induction by both agonists and partial agonists. Proc. Natl. Acad. Sci. USA, 93: 9736-9741, 1996.
52. Matsushita, S., and Nishimura, Y. Partial activation of human T cells by peptide analogs on live APC: induction of clonal anergy associated with protein tyrosine phosphorylation. Hum. Immunol., 53: 73-80, 1997.